Enterprise Ireland:企業のM&A・事業提携・投資動向

◆英語タイトル:Enterprise Ireland - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1534
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:210
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:政府系・NPO
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Enterprise Ireland – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Enterprise Ireland Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Enterprise Ireland since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Enterprise Ireland’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Enterprise Ireland. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Enterprise Ireland’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Enterprise Ireland and its subsidiaries since 2007.
- Information about key financial and legal advisors for Enterprise Ireland’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Enterprise Ireland’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 14
Corporate Venturing – Overview 14
Corporate Venturing – Deal reports 15
DIVESTMENTS 176
Divestments – Overview 176
Divestments – Deal reports 177
APPENDIX 200
Contact Us 200
About MarketLine Financial Deals Database 200
Deal Definition and Methodology 202
About MarketLine 209

List of Tables
Table 1: Enterprise Ireland M&A volume and value trend (2014-YTD2018)
Table 2: Enterprise Ireland M&A activity by geography (2014-YTD2018)
Table 3: Enterprise Ireland corporate venturing volume and value trend (2014-YTD2018)
Table 4: Enterprise Ireland corporate venturing by geography (2014-YTD2018)
Table 5: Enterprise Ireland divestments volume and value trend (2014-YTD2018)
Table 6: Enterprise Ireland divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Enterprise Ireland M&A volume and value trend (2014-YTD2018)
Figure 2: Enterprise Ireland M&A activity by geography (2014-YTD2018)
Figure 3: Enterprise Ireland corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Enterprise Ireland corporate venturing by geography (2014-YTD2018)
Figure 5: Enterprise Ireland divestments volume and value trend (2014-YTD2018)
Figure 6: Enterprise Ireland divestments by geography (2014-YTD2018)

★海外企業調査レポート[Enterprise Ireland:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Innoviva Inc (INVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Innoviva Inc (Innoviva) develops and commercializes small molecule medicines. It focuses on products for various respiratory disorders. The company partners with GSK for the commercialization and development of all its products. It receives royalty payments for its collaboration with GSK. In …
  • Kyochon F&B Co., Ltd.
    Kyochon F&B Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kyochon F&B Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ralph Lauren Corp:企業の戦略・SWOT・財務分析
    Ralph Lauren Corp - Strategy, SWOT and Corporate Finance Report Summary Ralph Lauren Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • OJSC Rosneft Oil Company:企業の戦略・SWOT・財務分析
    OJSC Rosneft Oil Company - Strategy, SWOT and Corporate Finance Report Summary OJSC Rosneft Oil Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Can-Fite BioPharma Ltd (CANF):企業の財務・戦略的SWOT分析
    Summary Can-Fite BioPharma Ltd (Can-Fite) is a clinical stage drug development Company that strives to develop small molecule drugs for the treatment of cancer and inflammatory diseases. The company’s pipeline products which are in phase II and III clinical development stage includes CF101, for rheu …
  • Industrias Nucleares do Brasil S.A.:企業の戦略的SWOT分析
    Industrias Nucleares do Brasil S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • CBR Systems Inc-製薬・医療分野:企業M&A・提携分析
    Summary CBR Systems Inc (CBR), a subsidiary of AMAG Pharmaceuticals Inc is a stem cell company that offers newborn stem cells. The company designs and implements technologies and processes for cord blood banking. It offers cord blood banking service that stores newborn's umbilical cord blood; and co …
  • Northbridge Financial Corporation:企業の戦略的SWOT分析
    Northbridge Financial Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • H. Lee Moffitt Cancer Center & Research Institute Inc-製薬・医療分野:企業M&A・提携分析
    Summary H. Lee Moffitt Cancer Center & Research Institute Inc (Moffitt) is a healthcare service provider that concentrates on the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. The center offers medical services suc …
  • DesignMedix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary DesignMedix Inc (DesignMedix) is a biotechnology company that develop drugs to overcome drug resistance in multiple diseases such as malaria and diarrhea. The company develops malaria cure drugs, malaria preventive drugs and anti-bacterial drugs. It develops DM1157, a drug candidate that pro …
  • Koninklijke Philips N.V. (PHIA)-エネルギー分野:企業M&A・提携分析
    Summary Koninklijke Philips N.V. (Philips) is a diversified technology company which focuses on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The company develops and manufactures medical …
  • MAXrad SOFTware (India) Pvt. Ltd.:企業の戦略・SWOT・財務情報
    MAXrad SOFTware (India) Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report Summary MAXrad SOFTware (India) Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Benitec Biopharma Ltd (BLT):医療機器:M&Aディール及び事業提携情報
    Summary Benitec Biopharma Ltd (Benitec) is a clinical stage biotechnology company. The company develops novel therapeutics for the treatment of chronic and life threatening diseases based on its proprietary gene silencing DNA directed RNA interference (ddRNAi) technology. It develops ddRNAi based th …
  • Exosome Diagnostics Inc:企業の製品パイプライン分析
    Summary Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. Exosome Diagnostics’ services comprise miRNA profiling, mRNA p …
  • Collegium Pharmaceutical Inc (COLL)-医療機器分野:企業M&A・提携分析
    Summary Collegium Pharmaceutical Inc (Collegium) is a healthcare products provider that develops chronic pain and oral drug delivery solutions. The company's lead candidate, Xtampza ER, is an abuse-deterrent, extended-release, oral formulation of oxycodone that uses DETERx technology for the long-te …
  • Barton Malow Company:企業の戦略・SWOT・財務情報
    Barton Malow Company - Strategy, SWOT and Corporate Finance Report Summary Barton Malow Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • PT Bank Danamon Indonesia Tbk (BDMN):企業の財務・戦略的SWOT分析
    PT Bank Danamon Indonesia Tbk (BDMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Ambry Genetics Corp-製薬・医療分野:企業M&A・提携分析
    Summary Ambry Genetics Corp (Ambry Genetics) is a biotechnology company that offers genetic testing services. The company offers clinical diagnostics services, which include tests, forms, billing, managed care, order kits, reporting, licenses, family studies program, variant classification and secur …
  • Bank of Shanghai Co., Ltd.:企業の戦略・SWOT・財務情報
    Bank of Shanghai Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank of Shanghai Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • PTC Therapeutics Inc (PTCT):製薬・医療:M&Aディール及び事業提携情報
    Summary PTC Therapeutics Inc (PTC Therapeutics) discovers, develops, and commercializes orally active small molecule therapeutics that target post transcriptional control. The company's pipeline products include an orally administered small-molecule targeted at genetic disorders due to a nonsense mu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆